March 10, 2025, was the date when the FDA announced the recall of several Zaarah Herbals products that were distributed by New York Wholesale Group LLC, immediately in conjunction with the Connecticut Department of Consumer Protection (DCP) and Connecticut Agricultural Experiment Station (CAES). The Zaarah Herbals products recalled include Rasayan Churan, Gurmar Powder, Vasaka Powder, and Bhringraj Powder. These products have been a staple of Ayurvedic and natural wellness practices, marketed as herbal supplements to promote health benefits. [1]

Zaarah Herbals Powders by New York Wholesale Group LLC (USA)

Recall , May 15, 2025

March 10, 2025, was the date when the FDA announced the recall of several Zaarah Herbals products that were distributed by New York Wholesale Group LLC, immediately in conjunction with the Connecticut Department of Consumer Protection (DCP) and Connecticut Agricultural Experiment Station (CAES). The Zaarah Herbals products recalled include Rasayan Churan, Gurmar Powder, Vasaka Powder, and Bhringraj Powder. These products have been a staple of Ayurvedic and natural wellness practices, marketed as herbal supplements to promote health benefits. [1]

Reason Behind the Recall

The recall was initiated after it was found through random testing that many batches contained dangerously high levels of lead and arsenic, heavy metals which are considered toxic contaminants by the FDA and other worldwide agencies. Ingestion over time, even in small quantities, of these toxins can accumulate in human tissues, leading to severe health consequences, including kidney failure, impaired neurological functions, reproductive difficulties, and cancer. [2]

Root Cause Analysis

The contamination was likely caused by two main reasons:

  1. Inadequate Quality control: No application of standardized heavy metal testing protocol was done before the distribution of any products. There seems to be no evidence for any compliance with USP (United States Pharmacopeia) General Chapter <233> regarding elemental impurity limits in dietary supplements or Chapter <2232> showing the methods for analyzing substances.
  2. Source from contaminated region: It is possible that raw herbal powders are collected from regions of high environmental pollution, those which mainly are agricultural zones in South Asia, where industrial pollutants penetrate the soil and groundwater. Without verification of source documentation or Certificates of Analysis (CoAs), the risks from cross-contamination increase dramatically.[3]

Product Description

  • Brand: Zaarah Herbals
  • Distribution Company Name: New York Wholesale Group LLC
  • Product From: Botanical Powder (Fine Powdered)
  • Product Type Affected:
  • Bhringraj Powder
  • Gurmar Powder
  • Vasaka Powder
  • Rasayan Churan
  • Packaging: Clear 100g (3.5 oz) jars with gold lids
  • Upon Market Uses: For hair growth, blood sugar support, respiratory health, and overall well-being
  • Distribution Channels: Stores in New York, New Jersey, Connecticut, and California
  • Distribution Dates: December 20, 2024 – January 7, 2025

Affected Lot Numbers along with UPCs:

Product DescriptionBatch No.Mfd. DateUPC
Bhringraj PowderBJ 04July 2022635028 999731
Gurmar PowderGD 04July 2022635028 999694
Vasaka PowderVK 04July 2022635028 999670
Rasayan ChuranRY 04July 2022635028 999663

 

All these codes shall be found on the panel in the back of all bottles. (U.S. Food and Drug Administration) [1] 

Issue Identified

The permissible levels of lead and arsenic in dietary supplements established by the FDA were 10 ppm for lead and 3 ppm for arsenic. Testing did reflect levels between 35 ppm for lead and 9 ppm for arsenic in some batches, far exceeding safety standards permitted by the federal jurisdiction.

 

Such concentrations are regarded as acutely toxic to:

  • Pregnant women and children
  • People with pre-existing liver or kidney diseases
  • Long-term users of herbal or Ayurvedic medicines
The Science Behind the Supplement Building Trust with Evidence-Based Claims_FRL

Heavy metals usually show toxicity signs in the course of time, and some symptoms are:

  • Chronic fatigue
  • Memory loss
  • Gastrointestinal distress
  • Cognitive deficits
  • Skin rashes [4]

Regulatory Body Concerns

According to the FDA’s classification of the Zaarah Herbals products as adulterated under Section 402(a)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), the products are prohibited from being sold where harmful or deleterious substances are present.

 

In addition, for states such as California, the products are also noncompliant with Proposition 65 (Safe Drinking Water and Toxic Enforcement Act), which requires all products containing substances known to cause cancer or reproductive harm to display warning labels.

The FDA’s response includes:

  • Formal consumer warnings
  • Withdrawal of the product from online and retail shelves
  • Import alerts for future shipments under the Zaarah label
  • Initiation of the audit of the manufacturer and inspection of the facility [5]

Manufacturer’s Consumer Guidance

New York Wholesale Group LLC undertakes a voluntary recall and calls upon all consumers to:

  • Stop using forthwith all Zaarah Herbal powders
  • Contact the point of sale for procedures for the refund
  • Dispose of the item safely or return any unopened ones to the distributor

 

No adverse effects have yet been reported to date; however, the company encourages consumers to seek medical attention in case of any health-related complaints allegedly linked with the product and report the case through FDA MedWatch. [6]

FRL Commentary

The recalls experienced by Zaarah Herbals illustrate the common problems present in the worldwide herbal industry: insufficient raw material testing and lack of traceability. Although traditional herbal treatments are seemingly still popular among consumers seeking alternative ways of wellness, manufacturers hardly ever keep up with modern scientific and regulatory standards.

 

The following preventative controls are advocated for botanical supplement brands by FRL:

  • Testing for heavy metals (lead, arsenic, cadmium, mercury) should be performed by a certified third-party lab.
  • Valid suppliers with contaminant-free growing systems should be preferred.
  • CoA (Certificate of Analysis) on a batch level should be submitted before product release.
  • A risk-based sampling plan should be implemented for higher-risk botanicals such as Rasayan Churan, Gurmar, Vasaka, and Bhringraj powders.

 

This unique incident reinforces the need for Good Manufacturing Practice (GMP) audits and pharmacognosy expertise to be included at every point in the product lifecycle-from the sourcing stage all the way through to post-market surveillance.

Concluding Remarks

The critical questions that arise from the recall of powders from Zaarah Herbals cover an area of regulatory oversight, vetting suppliers, and consumer safety in the ever-expanding field of herbal supplements. Even as Ayurveda and botanical sciences offer a great therapeutic legacy, public health stands compromised by commercializing these disciplines without scientific proof of efficacy and toxicological assurance.

 

This can serve as a cautionary benchmark for herbal brands at the global level. As stricter regulatory frameworks emerge and consumers continue to demand safer, scientifically validated natural products, manufacturers should not perceive quality assurance as another box to tick for compliance; rather, it becomes and should remain a core pillar of brand credibility.

 

For more information, visit the FDA Recall Notice – Zaarah Herbals Powders or contact New York Wholesale Group.